₹ 43.20
-1.69 (-3.76%)
BSE
G
Goldline Pharmaceutical
₹ 43.20
BSE
GLPL Fundamentals
Company Valuation
Market Cap (₹ Cr.)
41
PE Ratio
-
PB Ratio
2.14
Dividend Yield
-
ROE
27.37%
ROCE
38.46%
Book Value (₹)
21.00
Face Value (₹)
10.00
Analyse GLPL with 12+ custom fundamentals and financial ratios.
Share Holding Pattern
| Held By | Sep 2025 | May 2026 |
|---|---|---|
| Promoters | 79.71% | 79.71% |
| Domestic Institutional Investors (DII) | 0.00% | 0.00% |
| Foreign Institutional Investors (FII) | 0.00% | 0.00% |
| Public Investors | 0.00% | 0.00% |
| Government | 0.00% | 0.00% |
Promoters
Domestic Institutional Investors (DII)
Foreign Institutional Investors (FII)
Public Investors
Government
GLPL Investment Returns
Short Term
1 Week
1 Month
3 Months
6 Months
9 Months
Long Term
1 Year
2 Years
3 Years
4 Years
5 Years
- In Short Term
- In Long term
1 Week
1 Month
3 Months
6 Months
9 Months
Create Wealth in Longterm with Weekly and Monthly SIP in Stocks.
Stock & Sector Information
Sector
Sub Sector
Company Classification
SME
BSE Scrip Code
544759
NSE Scrip Name
GLPL
ISIN
INE1CLW01015



